M. Dioszegi

发表

A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands

D. Swinney, Jun Zhang, P. Beavis, 2014, British journal of pharmacology.

Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase.

K. Brew, H. Birkedal‐Hansen, H. V. Van Wart, 1990, Biochemistry.

Spiropiperidine CCR5 antagonists.

C. Brotherton-Pleiss, L. Setti, D. Rotstein, 2009, Bioorganic & medicinal chemistry letters.

Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities.

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Antiviral research.

Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H.

M. Dioszegi, G. Horváth, S. Bajusz, 1990, Journal of medicinal chemistry.

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

M Dioszegi, K Lindpaintner, P. Tacconi, 2001, Human molecular genetics.

CCR5 Small-Molecule Antagonists and Monoclonal Antibodies Exert Potent Synergistic Antiviral Effects by Cobinding to the Receptor

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Molecular Pharmacology.

The Second Extracellular Loop of CCR5 Contains the Dominant Epitopes for Highly Potent Anti-Human Immunodeficiency Virus Monoclonal Antibodies

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Antimicrobial Agents and Chemotherapy.

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

K. Lindpaintner, W. Hul, W. Wuyts, 2002, Journal of medical genetics.

Improved method for preparing aldehydes tripeptide.

Krishnendu Pal, M. Dioszegi, K. Szilágyi, 1990 .

[25] Vertebrate collagenases

H. E. Wart, M. Dioszegi, P. Cannon, 1995 .

Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation.

A. Falus, M. Dioszegi, D. Bagdy, 1982, Clinical and experimental immunology.

Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.

David G Myszka, D. Myszka, M. Dioszegi, 2006, Analytical biochemistry.

Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists.

D. Rotstein, M. Dioszegi, S. Sankuratri, 2010, Bioorganic & medicinal chemistry letters.

Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists

Jun Zhang, Jun Zhang, D. Rotstein, 2008, Molecular Pharmacology.

Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

U. Brinkmann, Jun Zhang, J. Nezu, 2011, Antimicrobial Agents and Chemotherapy.

Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists

Jun Zhang, Jun Zhang, D. Rotstein, 2008, Molecular Pharmacology.